;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Calithera sets IPO range

    Calithera Biosciences Inc. (South San Francisco, Calif.) amended its IPO on NASDAQ and now plans to sell 6 million shares at $13-$15. At $14, the company would raise $84 million and be valued at $222.3 million. …

    Published on 9/19/2014
  • FINANCIAL NEWS: Dermira sets IPO terms

    Dermira Inc. (Redwood City, Calif.) amended its IPO on NASDAQ and now plans to sell 5.3 million shares at $14-$16. At $15 the dermatology company would raise $80.3 million and be valued at $253.4 million. Citigroup; …

    Published on 9/19/2014
  • FINANCIAL NEWS: Exagen files for IPO

    Exagen Diagnostics Inc. (Vista, Calif.) filed to raise up to $69 million in an IPO on NASDAQ underwritten by Leerink; Baird; and William Blair.Exagen markets four products to diagnose rheumatic diseases. Its lead …

    Published on 9/19/2014
  • FINANCIAL NEWS: Microlin pulls IPO

    Microlin Bio Inc. (New York, N.Y.) withdrew its IPO on NASDAQ, citing market conditions. In June the company amended its IPO to sell 5.5 million units consisting of one share and one warrant at $4.50-$5.50. At $5, the …

    Published on 9/19/2014
  • FINANCIAL NEWS: USVP to raise $275M 11th fund

    U.S. Venture Partners is looking to raise up to $275 million for its U.S. Venture Partners XI fund, according to an SEC filing. The firm, which declined to discuss its fundraising, invests primarily in IT and healthcare…

    Published on 9/19/2014
  • FINANCIAL NEWS: Aglaia closes $65M for Oncology Fund II

    Dutch VC firm Aglaia BioMedical Ventures B.V. launched its Oncology Fund II with a $65 million close. The VC is aiming to raise $80-$100 million to invest in 10-15 cancer-focused biotech start-ups. Investors include …

    Published on 9/18/2014
  • FINANCIAL NEWS: Foamix trades up after $40.2M IPO

    Israeli dermatology play Foamix Ltd. (NASDAQ:FOMX) was up $0.22 to $6.22 in its first day of trading Thursday after raising $40.2 million through the sale of 6.7 million shares at $6 in an IPO on NASDAQ. The price …

    Published on 9/18/2014
  • FINANCIAL NEWS: OSE Pharma plans IPO on Euronext Paris

    Orphan Synergy Europe-Pharma S.A. plans an IPO on Euronext Paris by year end to fund clinical trials of its immunotherapy Texopi.Texopi is a combination of 10 epitopes targeting five tumor-associated antigens often …

    Published on 9/18/2014
  • FINANCIAL NEWS: Proteon files for IPO

    Proteon Therapeutics Inc. (Waltham, Mass.) filed to raise up to $69 million in an IPO on NASDAQ underwritten by Stifel; JMP Securities; Baird; and Oppenheimer.In August, Proteon began Phase III testing of PRT-201 …

    Published on 9/16/2014
  • FINANCIAL NEWS: Ribomic raises $25.7M in Japanese IPO

    Ribomic Inc. (Tokyo:4591) raised Y2.8 billion ($25.7 million) through the sale of 1.2 million shares at Y2,300 in an IPO on the Tokyo Stock Exchange's Mothers. The price values the company at Y27.8 billion ($258.3 …

    Published on 9/16/2014
  • FINANCIAL NEWS: University of California planning venture fund

    The University of California board of regents is set to vote on Thursday on a proposal to create an independent venture firm with up to $250 million to invest in commercial opportunities that emerge from UC system …

    Published on 9/16/2014
  • FINANCIAL NEWS: Civitas, Eyegate set IPO terms

    Civitas Therapeutics Inc. (Chelsea, Mass.) and EyeGate Pharmaceuticals Inc. (Waltham, Mass.) each set terms for their proposed IPOs on NASDAQ.Civitas plans to sell 5 million shares at $14-$16. At $15, Civitas would …

    Published on 9/15/2014
  • FINANCIAL NEWS: NeuroDerm files for IPO

    NeuroDerm Ltd. (Rehovot, Israel) filed to raise up to $65 million in an IPO on NASDAQ underwritten by Jefferies; Cowen; Oppenheimer; and Roth Capital Partners.NeuroDerm's lead program is ND0612L, a low-dose liquid …

    Published on 9/15/2014
  • FINANCIAL NEWS: Scholar Rock raises $20M series A

    Scholar Rock LLC (Cambridge, Mass.) raised $20 million in a series A round led by new investor Arch Venture Partners. Founding investors Polaris Partners and Timothy Springer joined new investors EcoR1 Capital and The …

    Published on 9/15/2014
  • FINANCIAL NEWS: Affimed raises $56M in IPO

    Affimed Therapeutics B.V. (NASDAQ:AFMD) was down $1.30 to $5.70 on its first day of trading Friday after raising $56 million through the sale of 8 million shares at $7 in an IPO. The IPO price values the company at $167…

    Published on 9/12/2014
  • FINANCIAL NEWS: AM-Pharma raises EUR 12.2M

    AM-Pharma B.V. (Bunnik, The Netherlands) raised EUR 12.2 million ($15.8 million) in a tranched series E round led by Gilde Healthcare.Existing investors participating in the new round included the venture arm of AbbVie…

    Published on 9/12/2014
  • FINANCIAL NEWS: Cancer play Kolltan files for IPO

    Kolltan Pharmaceuticals Inc. (New Haven, Conn.) filed to raise up to $86.3 million in an IPO on NASDAQ underwritten by Leerink Partners; Stifel; Guggenheim Securities; and Janney Montgomery Scott.Kolltan's KTN3379 is in…

    Published on 9/12/2014
  • FINANCIAL NEWS: Polar Capital raising large cap biotech fund

    Polar Capital is fundraising for an open-ended global biotech fund focused on large cap companies. The Polar Capital Healthcare Blue Chip Fund will be managed by Gareth Powell and Daniel Mahony, who have both been with …

    Published on 9/12/2014
  • FINANCIAL NEWS: Virobay files for IPO

    Virobay Inc. (Menlo Park, Calif.) filed to raise up to $50 million in an IPO on NASDAQ underwritten by Piper Jaffray; JMP Securities; Cantor Fitzgerald; and Summer Street Research Partners.Virobay has completed Phase I …

    Published on 9/11/2014
  • FINANCIAL NEWS: Xenon files for IPO

    Xenon Pharmaceuticals Inc. (Burnaby, B.C.) filed to raise up to $51.8 million in an IPO on NASDAQ underwritten by Jefferies and Wells Fargo Securities. Xenon uses its Extreme Genetics platform to discover and develop …

    Published on 9/10/2014
  • FINANCIAL NEWS: Aerie planning $125M note deal

    Aerie Pharmaceuticals Inc. (NASDAQ:AERI) proposed Tuesday to raise $125 million through the sale of senior secured convertible notes to Deerfield Management Company L.P. The notes bear 1.75% interest, mature in …

    Published on 9/9/2014
  • FINANCIAL NEWS: OrbiMed closes new Asia fund with $325M

    OrbiMed Advisors closed its second Asia fund with $325 million, above the firm's $300 million target. According to OrbiMed general partner Carter Neild, OrbiMed will invest OrbiMed Asia Partners II L.P. in 15 to 20 "…

    Published on 9/9/2014
  • FINANCIAL NEWS: Newco Flex raises $40 million in venture round

    Flex Pharma Inc. (Boston, Mass.) raised $40 million in an undisclosed venture round to develop treatments for neuromuscular disorders. Investors include Longwood Fund; Bessemer Venture Partners; EcoR1 Capital; Jennison …

    Published on 9/8/2014
  • FINANCIAL NEWS: PRA Health files for $375 million IPO

    CRO PRA Health Sciences Inc. (Raleigh, N.C.) filed to raise up to $375 million in an IPO on NASDAQ underwritten by Jefferies; Citigroup; KKR; UBS Investment Bank; Credit Suisse; Wells Fargo Securities; Baird; and …

    Published on 9/8/2014
  • FINANCIAL NEWS: ProQR sets IPO range

    ProQR Therapeutics B.V. (Leiden, the Netherlands) set terms for its IPO on NASDAQ. The company plans to sell 6.3 million shares at $11-$13. At the $12 midpoint, the company would raise $75 million and be valued at $251.…

    Published on 9/8/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993